UNITY Biotechnology Reports Granting of New Employment Inducement Award

Core Viewpoint - UNITY Biotechnology, Inc. has granted a stock-based award to its new Chief Medical Officer, Federico Grossi, as part of its strategy to attract talent in the biotechnology sector focused on aging-related therapeutics [1][2]. Group 1: Stock-Based Award - The Compensation Committee of the Board granted options to purchase 150,000 shares of common stock to Federico Grossi [1]. - This award is part of the UNITY 2020 Employment Inducement Incentive Plan, which was approved by the Board in March 2020 [2]. Group 2: Company Focus - UNITY is developing therapeutics aimed at slowing, halting, or reversing diseases associated with aging, with a particular focus on age-related ophthalmologic and neurologic diseases [3].